US 12,403,160 B2
Injection composition containing isolated mitochondria, and use thereof
Young-Cheol Kang, Wonju-si (KR); Kyuboem Han, Daejeon (KR); Sang-Min Lim, Incheon (KR); Hahnsun Jung, Gunpo-si (KR); Hye Jeong Hwang, Cheongju-si (KR); and Junyoung Son, Seoul (KR)
Assigned to Paean Biotechnology Inc., Daejeon (KR)
Appl. No. 18/044,559
Filed by Paean Biotechnology Inc., Daejeon (KR)
PCT Filed Aug. 10, 2021, PCT No. PCT/KR2021/010592
§ 371(c)(1), (2) Date Mar. 8, 2023,
PCT Pub. No. WO2022/055134, PCT Pub. Date Mar. 17, 2022.
Claims priority of application No. 10-2020-0116285 (KR), filed on Sep. 10, 2020.
Prior Publication US 2023/0270780 A1, Aug. 31, 2023
Int. Cl. A61K 35/12 (2015.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 47/18 (2017.01); A61K 47/26 (2006.01)
CPC A61K 35/12 (2013.01) [A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01)] 16 Claims
 
1. A liquid composition for injection comprising an effective amount of glycine, saccharide, buffer, and mitochondria.